PXD068873 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR |
| Description | Uveal melanoma (UM) is a high fatality cancer. It arises in the eye and spreads (metastasizes) to the liver in 50% of affected patients, with a low survival rate of 5 years. In >85% of patients, their ocular tumors have mutations in specific genes, GNAQ and GNA11, leading to tumor progression and metastasis. Conventional therapies such as surgery, chemotherapy, and irradiation halt tumor progression in the eye. Unfortunately, once cancer progresses to metastasis (usually occurring at early stages of the disease), the patients have limited treatment options. Moreover, targeted therapies and immunotherapies fail to achieve more significant survival benefits due to UM's emergence of resistance. Therefore, there is an urgent need to develop new therapeutic strategies to treat UM. This project explores the use of 2 small molecule inhibitors , which suppresses MNK1/2-eIF4E (SEL201) and mTORC1/2-4EBP1 (INK128), as a strategy to block the progression of UM to invasive and metastatic disease. Our data shows that both inhibitors work in concert to decrease clonogenicity and invasiveness of some, but not all, UM cell lines screened. To define the mechanism by which MNK1/2 blockade augments the efficacy of mTOR inhibitors in UM, we performed a discovery approach where T128 UM cells were treated with the drug combination for 24h and sent for DIA MS analysis. The analysis showed that protein vesicle trafficking, driven mainly RAB1A, was being downregulated in the combination treatment, which translated to decreased invasive and clonogenic potential. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-02-20 |
| AnnouncementXML | Submission_2026-02-20_10:32:30.103.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Raul Ernesto Flores Gonzalez |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | timsTOF |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-09-26 12:13:25 | ID requested | |
| ⏵ 1 | 2026-02-20 10:32:31 | announced | |
Publication List
| Flores-Gonz, á, lez RE, Goncalves C, Wirasinghe N, Gaudreault V, Noda Ferro JM, Coutant K, Mitchell A, Papadopoulos T, Cho YY, Guettler E, Gonz, á, lez-Moreno DR, Preston S, Cai F, Gagnon N, Jean S, Landreville S, Miller WH, Del Rinc, ó, n SV, RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR. Cell Death Differ, ():(2026) [pubmed] |
| 10.1038/s41418-026-01684-y; |
Keyword List
| submitter keyword: uveal melanoma, liver metastasis.,MNK1/2, RAB1A, mTOR |
Contact List
| Sonia del Rincon |
| contact affiliation | Lady Davis Institute for Medical Research - Jewish General Hospital - McGill University |
| contact email | soniavictoria.delrincon@mcgill.ca |
| lab head | |
| Raul Ernesto Flores Gonzalez |
| contact affiliation | Lady Davis Institute-Jewish General Hospital - McGill University |
| contact email | raul.floresgonzalez2@mail.mcgill.ca |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/02/PXD068873 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD068873
- Label: PRIDE project
- Name: RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR